DrugBiological
Romiplostim clinical trials
Also written Nplate, AMG 531 and GNR-069.
- studies test it
- 88
- open now
- 28
- in phase 3
- 25
- first study started
- 2002
Keep track of what changes. Save the romiplostim studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
- Nplate
- 22
Combined with it in one product
Studies by the year they started
88 studies that test it; most in 2026 (13)
| Year | Studies |
|---|---|
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 8 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 8 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 9 |
| 2026 | 13 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 10
- Phase 2
- 51
- Phase 3
- 25
- Phase 4
- 6
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 37 · Other 51
Amgen (24) · Peking Union Medical College Hospital (8) · Kyowa Kirin Co., Ltd. (5) · Memorial Sloan Kettering Cancer Center (4) · The First Affiliated Hospital of Soochow University (3) · Geropharm (2) · AO GENERIUM (2) · Kyowa Kirin China Pharmaceutical Co., Ltd. (2)
Often tested with
Tested in the same studies.
Eltrombopag (3) · Rituximab (3) · Dexamethasone (2) · Cyclosporine (2) · Carboplatin (1) · Thrombopoietin Receptor Agonist (1) · Orelabrutinib (1) · Prednisolone (1)
Studies
Open first, then newest update. How each study uses romiplostim is read from its arms, and is right about nine times in ten.
Testing it · 88
- Combination Therapy of Romiplostim and Erythropoiesis-stimulating AgentsRecruitingPhase 2Chinese University of Hong KongNCT07854561Written as Romiplostim
- Efficacy and Safety of Romiplostim N01 for Injection in Promoting Platelet Reconstitution After Allogeneic Hematopoietic Stem Cell TransplantationNot yet recruitingPhase 2The First Affiliated Hospital of Henan University of Science and TechnologyNCT07829952Written as Romiplostim N01
- A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)RecruitingPhase 3AmgenNCT07700238Written as Romiplostim
- Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treatment of LeukemiaRecruitingPhase 2Anhui Provincial HospitalNCT06898983Written as Romiplostim N01
- Romiplostim N01 for Injection for Secondary Prophylaxis of CIT in Breast CancerNot yet recruitingPhase 2Fudan UniversityNCT07771881Written as Romiplostim N01
- Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery.RecruitingPhase 2Nantes University HospitalNCT07278661Written as Nplate
- Romiplostim for Oral TPO-RA Resistant ITPRecruitingNot applicableThe First Affiliated Hospital of Soochow UniversityNCT07612319Written as Romiplostim
- Romiplostim N01 in Chemoradiotherapy-induced Aplastic AnemiaNot yet recruitingPhase 2Peking Union Medical College HospitalNCT07572084Written as Romiplostim N01
- Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer PatientsRecruitingPhase 2Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT07043894Written as Romiplostim N01
- CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAANot yet recruitingPhase 2Peking Union Medical College HospitalNCT07558434Written as Romiplostim N01
- Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AARecruitingPhase 2The First Affiliated Hospital of Soochow UniversityNCT07400341Written as Romiplostim
- A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11RecruitingPhase 3The First Affiliated Hospital with Nanjing Medical UniversityNCT06759636Written as Romiplostim N01
- Single Arm Romiplostim to Prevent CITRecruitingEarly Phase 1Children's Hospital Medical Center, CincinnatiNCT07048249Written as Romiplostim (AMG-531)
- Phase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of TherapyNot yet recruitingPhase 2Peking Union Medical College HospitalNCT07400250Written as Romiplostim N01
- Romiplostim N01 for Platelet Recovery After Haploidentical HSCTRecruitingPhase 1First Affiliated Hospital of Zhejiang UniversityNCT07321626Written as Romiplostim N01
- A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic AnemiaNot yet recruitingPhase 3Qilu Pharmaceutical Co., Ltd.NCT07345000Written as Romiplostim N01
- Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune ThrombocytopeniaRecruitingNot applicableThe First Affiliated Hospital of Soochow UniversityNCT07206823Written as Romiplostim N01
- A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid TumorsNot yet recruitingNot applicableJun wangNCT07185893Written as Romiplostim N01
- Romiplostim N01 in the Treatment of Thrombocytopenia Caused by Cytotoxic Drugs in Breast Cancer PatientsNot yet recruitingNot applicableTianjin Medical University Cancer Institute and HospitalNCT07162519Written as romiplostim N01
- Romiplostim N01 for the Treatment of Thrombocytopenia Associated With Radiotherapy-Combined Treatment Regimens in Patients With Solid TumorsNot yet recruitingPhase 2Zhujiang HospitalNCT07128576Written as Romiplostim N01
See all 88 studies that test romiplostim →
Given in every arm · 5 — romiplostim is usual care beside what is tested
- High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With SplenomegalyRecruitingPhase 2M.D. Anderson Cancer CenterNCT06345495Written as Romiplostim
- Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid TumorsRecruitingPhase 2Peking University People's HospitalNCT07586813Written as Romiplostim N01
- Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid TumorsRecruitingPhase 2Peking University People's HospitalNCT07586826Written as Romiplostim N01
- UI-Romi-02; Romiplostim Added to Standard of Care for Treatment Naive and Relapsed or Refractory Severe Aplastic AnemiaWithdrawnPhase 2Anjali SharathkumarNCT07001254Written as Romiplostim
- Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive TherapyWithdrawnPhase 2AmgenNCT05323617Written as Romiplostim
Codes
What other systems call romiplostim · ClinicalTrials.gg INT004684
- MeSH (NLM) C488777romiplostimOne source NLM
- UNII (FDA) GN5XU2DXKVROMIPLOSTIMConfirmed FDA, NLM, Wikidata
- RxNorm 805452Confirmed FDA, Wikidata
- Wikidata Q1235195romiplostimConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C52183RomiplostimConfirmed FDA, Wikidata
- DrugBank DB05332One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C488777 | romiplostim | One source NLM |
| UNII (FDA) | GN5XU2DXKV | ROMIPLOSTIM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 805452 | — | Confirmed FDA, Wikidata |
| Wikidata | Q1235195 | romiplostim | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C52183 | Romiplostim | Confirmed FDA, Wikidata |
| DrugBank | DB05332 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.